Accessibility Menu
Cannara Biotech logo

Cannara Biotech

(OTC) LOVFF

Current Price$1.16
Market Cap$115.58M
Since IPO (2019)-35%
5 Year-13%
1 Year+27%
1 Month-6%

Cannara Biotech Financials at a Glance

Market Cap

$115.58M

Revenue (TTM)

CA$113.26M

Net Income (TTM)

CA$10.16M

EPS (TTM)

$0.08

P/E Ratio

14.79

Dividend

$0.00

Beta (Volatility)

0.05 (Low)

Price

$1.16

Volume

26,936

Open

$1.19

Previous Close

$1.16

Daily Range

$1.16 - $1.22

52-Week Range

$0.90 - $1.47

Estimated Earnings Date

Jul 15, 2026

LOVFF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannara Biotech

Industry

Personal Products

Employees

452

CEO

Zohar Krivorot

Headquarters

Saint-Laurent, QC H4N 3M9, CA

LOVFF Financials

Key Financial Metrics (TTM)

Gross Margin

39%

Operating Margin

14%

Net Income Margin

10%

Return on Equity

10%

Return on Capital

11%

Return on Assets

7%

Earnings Yield

6.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$115.58M

Shares Outstanding

98.78M

Volume

26.94K

Avg. Volume

11.92K

Financials (TTM)

Gross Profit

CA$47.22M

Operating Income

CA$22.20M

EBITDA

CA$28.18M

Operating Cash Flow

CA$20.01M

Capital Expenditure

-CA$6.36M

Free Cash Flow

CA$13.65M

Cash & ST Invst.

CA$14.36M

Total Debt

CA$41.58M

Cannara Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$27.18M

+2.2%

Gross Profit

CA$11.65M

-2.6%

Gross Margin

42.86%

N/A

Market Cap

$115.58M

N/A

Market Cap/Employee

$250.71K

N/A

Employees

461

N/A

Net Income

CA$1.66M

-49.8%

EBITDA

CA$4.63M

-36.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$21.90M

+333.3%

Total Debt

CA$34.22M

-30.0%

Accounts Receivable

CA$12.47M

-19.9%

Inventory

CA$54.15M

+19.2%

Long Term Debt

CA$25.22M

-26.0%

Short Term Debt

CA$9.00M

-39.1%

Return on Assets

6.79%

N/A

Return on Invested Capital

11.14%

N/A

Free Cash Flow

-CA$286.30K

+92.9%

Operating Cash Flow

CA$2.95M

+215.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOYFBioSyent Inc.
$9.85-0.91%
GRUSFGrown Rogue International Inc.
$0.43+0.21%
HLTRFHLS Therapeutics Inc.
$3.16+0.31%
ORXOYOrexo AB (publ)
$2.00+11.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$191.82-0.05%
AALAmerican Airlines Group
$15.42-0.02%
SOFISoFi Technologies
$17.42-0.02%
NOKNokia
$13.83-0.01%

Questions About LOVFF

What is the current price of Cannara Biotech?

Cannara Biotech is trading at $1.16 per share.

What is the 52-week range for Cannara Biotech?

Over the past 52 weeks, Cannara Biotech has traded between $0.90 and $1.47.

How much debt does Cannara Biotech have?

As of the most recent reporting period, Cannara Biotech reported total debt of CA$25.09M.

How much cash does Cannara Biotech have on hand?

Cannara Biotech reported CA$16.06M in cash and cash equivalents in its most recent financial results.

What is Cannara Biotech’s dividend yield?

Cannara Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.